{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T13:54:32Z","timestamp":1783691672621,"version":"3.55.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T00:00:00Z","timestamp":1760313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T00:00:00Z","timestamp":1760313600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"National Program of Neurosciences and Neurotechnology","award":["PN305LH013-034"],"award-info":[{"award-number":["PN305LH013-034"]}]},{"name":"National Program of Neurosciences and Neurotechnology","award":["PN305LH013-034"],"award-info":[{"award-number":["PN305LH013-034"]}]},{"name":"National Program of Neurosciences and Neurotechnology","award":["PN305LH013-034"],"award-info":[{"award-number":["PN305LH013-034"]}]},{"name":"National Program of Neurosciences and Neurotechnology","award":["PN305LH013-034"],"award-info":[{"award-number":["PN305LH013-034"]}]},{"name":"National Program of Neurosciences and Neurotechnology","award":["PN305LH013-034"],"award-info":[{"award-number":["PN305LH013-034"]}]},{"name":"National Program of Neurosciences and Neurotechnology","award":["PN305LH013-034"],"award-info":[{"award-number":["PN305LH013-034"]}]},{"name":"National Program of Neurosciences and Neurotechnology","award":["PN305LH013-034"],"award-info":[{"award-number":["PN305LH013-034"]}]},{"DOI":"10.13039\/100005156","name":"Alexander von Humboldt-Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005156","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Cuban Ministry of Public Health"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cerebellum"],"DOI":"10.1007\/s12311-025-01917-9","type":"journal-article","created":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T02:46:44Z","timestamp":1760323604000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Elevated Interleukin-8 in Spinocerebellar Ataxia Type 2: A Distinct Peripheral Immune Signature Unrelated To Disease Severity"],"prefix":"10.1007","volume":"24","author":[{"given":"Yaime\u00e9","family":"V\u00e1zquez-Mojena","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3193-7683","authenticated-orcid":false,"given":"Roberto","family":"Rodr\u00edguez-Labrada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanetsy","family":"C\u00f3rdova-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yennis","family":"Dom\u00ednguez-Barrios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana Iris","family":"Zamora-Loyarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario E.","family":"Fern\u00e1ndez-Herrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Pav\u00f3n-Fuentes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8879-3839","authenticated-orcid":false,"given":"Maria","family":"de los Angeles Robinson-Agramonte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1628-2703","authenticated-orcid":false,"given":"Luis","family":"Vel\u00e1zquez-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,13]]},"reference":[{"key":"1917_CR1","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/ng1196-269","volume":"14","author":"S-M Pulst","year":"1996","unstructured":"Pulst S-M, Nechiporuk A, Nechiporuk T, Gispert S, Chen X-N, Lopes-Cendes I, et al. Moderate expansion of a normally biallelic trinucleotide repeat in spinocerebellar ataxia type 2. Nat Genet. 1996;14:269\u201376 https:\/\/www.nature.com\/articles\/ng1196-269.","journal-title":"Nat Genet."},{"key":"1917_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-06812-5","volume":"15","author":"RG Costa","year":"2024","unstructured":"Costa RG, Concei\u00e7\u00e3o A, Matos CA, N\u00f3brega C. The polyglutamine protein ATXN2: from its molecular functions to its involvement in disease. Cell Death Dis. 2024;15:415. https:\/\/doi.org\/10.1038\/s41419-024-06812-5.","journal-title":"Cell Death Dis"},{"key":"1917_CR3","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1002\/mds.28729","volume":"36","author":"PP Li","year":"2021","unstructured":"Li PP, Moulick R, Feng H, Sun X, Arbez N, Jin J, et al. RNA toxicity and perturbation of rRNA processing in spinocerebellar ataxia type 2. Mov Disord. 2021;36:2519\u201329. https:\/\/doi.org\/10.1002\/mds.28729.","journal-title":"Mov Disord"},{"key":"1917_CR4","unstructured":"Li PP, Sun X, Xia G, Arbez N, Paul S, Zhu S et al. ATXN2-AS, a gene antisense to ATXN2, is associated with SCA2 and ALS. Ann Neurol. 2016."},{"key":"1917_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2017.00472","volume":"8","author":"LC Vel\u00e1zquez-P\u00e9rez","year":"2017","unstructured":"Vel\u00e1zquez-P\u00e9rez LC, Rodr\u00edguez-Labrada R, Fernandez-Ruiz J. Spinocerebellar ataxia type 2: clinicogenetic aspects, mechanistic insights, and management approaches. Front Neurol. 2017;8:472.","journal-title":"Front Neurol"},{"key":"1917_CR6","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1007\/s13311-019-00777-6","volume":"16","author":"PA Egorova","year":"2019","unstructured":"Egorova PA, Bezprozvanny IB. Molecular mechanisms and therapeutics for spinocerebellar ataxia type 2. Neurotherapeutics. 2019;16:1050\u201373. https:\/\/doi.org\/10.1007\/s13311-019-00777-6.","journal-title":"Neurotherapeutics"},{"key":"1917_CR7","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1093\/hmg\/ddaa072","volume":"29","author":"DR Scoles","year":"2020","unstructured":"Scoles DR, Dansithong W, Pflieger LT, Paul S, Gandelman M, Figueroa KP, et al. ALS-associated genes in SCA2 mouse spinal cord transcriptomes. Hum Mol Genet. 2020;29:1658\u201372 https:\/\/academic.oup.com\/hmg\/article\/29\/10\/1658\/5822587.","journal-title":"Hum Mol Genet."},{"key":"1917_CR8","doi-asserted-by":"crossref","unstructured":"Canet-Pons J, Sen N, Arsovi\u0107 A, Almaguer-Mederos L-E, Halbach MV, Key J, et al. Atxn2-CAG100-KnockIn mouse spinal cord shows progressive TDP43 pathology associated with cholesterol biosynthesis suppression. Neurobiol Dis. 2021;152:105289\u00a0https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996121000383.","DOI":"10.1016\/j.nbd.2021.105289"},{"key":"1917_CR9","doi-asserted-by":"publisher","first-page":"7484","DOI":"10.1038\/s41467-024-51676-0","volume":"15:","author":"Vieira de S\u00e1 R","year":"2024","unstructured":"de S\u00e1 R Vieira, Sudria-Lopez E, Ca\u00f1izares Luna M, Harschnitz O, van den Heuvel DMA, Kling S, et al. ATAXIN-2 intermediate-length polyglutamine expansions elicit ALS-associated metabolic and immune phenotypes. Nat Commun. 2024;15:7484.\u00a0https:\/\/www.nature.com\/articles\/s41467-024-51676-0.","journal-title":"Nat Commun"},{"key":"1917_CR10","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1002\/mds.29359","volume":"38","author":"Y V\u00e1zquez-Mojena","year":"2023","unstructured":"V\u00e1zquez-Mojena Y, Rodr\u00edguez\u2010C\u00f3rdova Y, Dominguez\u2010Barrios Y, Le\u00f3n\u2010Arcia K, Miranda\u2010Becerra D, Gonzalez\u2010Zaldivar Y, et al. Peripheral inflammation links with the severity of clinical phenotype in spinocerebellar ataxia 2. Mov Disord. 2023;38:880\u20135. https:\/\/doi.org\/10.1002\/mds.29359.","journal-title":"Mov Disord"},{"key":"1917_CR11","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1007\/s12311-024-01665-2","volume":"23","author":"Y V\u00e1zquez-Mojena","year":"2024","unstructured":"V\u00e1zquez-Mojena Y, Rodr\u00edguez-Labrada R, C\u00f3rdova-Rodr\u00edguez Y, Dom\u00ednguez-Barrios Y, Fern\u00e1ndez-Herrera ME, Le\u00f3n-Arcia K, et al. Serum S100\u03b2 levels are linked with cognitive decline and peripheral inflammation in spinocerebellar ataxia type 2. Cerebellum. 2024;23:1509\u201320. https:\/\/doi.org\/10.1007\/s12311-024-01665-2.","journal-title":"Cerebellum"},{"key":"1917_CR12","doi-asserted-by":"publisher","unstructured":"Pahan K. Cytokines in Neurodegenerative Disorders. Neuroimmune Pharmacol Ther. Cham: Springer Nature Switzerland; 2024. pp. 189\u2013205.\u00a0https:\/\/link.springer.com\/https:\/\/doi.org\/10.1007\/978-3-031-68237-7_12","DOI":"10.1007\/978-3-031-68237-7_12"},{"key":"1917_CR13","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/s41392-023-01486-5","volume":"8","author":"W Zhang","year":"2023","unstructured":"Zhang W, Xiao D, Mao Q, Xia H. Role of neuroinflammation in neurodegeneration development. Signal Transduct Target Ther. 2023;8:267.\u00a0https:\/\/www.nature.com\/articles\/s41392-023-01486-5","journal-title":"Signal Transduct Target Ther"},{"key":"1917_CR14","doi-asserted-by":"crossref","unstructured":"Gao C, Jiang J, Tan Y, Chen S. Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets. Signal Transduct Target Ther. 2023;8:359.\u00a0https:\/\/www.nature.com\/articles\/s41392-023-01588-0","DOI":"10.1038\/s41392-023-01588-0"},{"key":"1917_CR15","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1007\/s12311-015-0719-z","volume":"15","author":"G da Silva Carvalho","year":"2016","unstructured":"da Silva Carvalho G, Saute JAM, Haas CB, Torrez VR, Brochier AW, Souza GN, et al. Cytokines in Machado Joseph disease\/spinocerebellar ataxia 3. Cerebellum. 2016;15:518\u201325. https:\/\/doi.org\/10.1007\/s12311-015-0719-z.","journal-title":"Cerebellum"},{"key":"1917_CR16","first-page":"5389","volume":"21","author":"BO Evert","year":"2001","unstructured":"Evert BO, Vogt IR, Kindermann C, Ozimek L, Vos RAI, De, Brunt ERP, et al. Inflammatory genes are upregulated in expanded Ataxin-3- expressing cell lines and spinocerebellar ataxia type 3. Brains. 2001;21:5389\u201396.","journal-title":"Brains"},{"key":"1917_CR17","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s12017-016-8416-8","volume":"19","author":"M Raposo","year":"2017","unstructured":"Raposo M, Bettencourt C, Ramos A, Kazachkova N, Vasconcelos J, Kay T, et al. Promoter variation and expression levels of inflammatory genes IL1A, IL1B, IL6 and TNF in blood of spinocerebellar ataxia type 3 (SCA3) patients. Neuromolecular Med. 2017;19:41\u20135. https:\/\/doi.org\/10.1007\/s12017-016-8416-8.","journal-title":"Neuromolecular Med"},{"key":"1917_CR18","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1212\/01.wnl.0000219042.60538.92","volume":"66","author":"T Schmitz-Hubsch","year":"2006","unstructured":"Schmitz-Hubsch T, du Montcel ST, Baliko L, Berciano J, Boesch S, Depondt C et al. Scale for the assessment and rating of ataxia: Development of a new clinical scale. Neurology. 2006;66:1717\u201320.\u00a0https:\/\/www.neurology.org\/lookup\/doi\/https:\/\/doi.org\/10.1212\/01.wnl.0000219042.60538.92","journal-title":"Neurology"},{"key":"1917_CR19","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1212\/01.wnl.0000325057.33666.72","volume":"71","author":"T Schmitz-H\u00fcbsch","year":"2008","unstructured":"Schmitz-H\u00fcbsch T, Coudert M, Bauer P, Giunti P, Globas C, Baliko L, et al. Spinocerebellar ataxia types 1, 2, 3, and 6: disease severity and nonataxia symptoms. Neurology. 2008;71:982\u20139.","journal-title":"Neurology"},{"key":"1917_CR20","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1093\/brain\/awx317","volume":"141","author":"F Hoche","year":"2017","unstructured":"Hoche F, Guell X, Vangel MG, Sherman JC, Schmahmann JD. The cerebellar cognitive affective \/ Schmahmann syndrome scale. Brain. 2017;141:248\u201370.","journal-title":"Brain"},{"key":"1917_CR21","doi-asserted-by":"crossref","unstructured":"Zahorec R. Neutrophil-to-lymphocyte ratio, past, present and future perspectives. Bratislava Med J. 2021;122:474\u201388. http:\/\/www.elis.sk\/index.php?page=shop.product_details&flypage=flypage.tpl&product_id=7271&category_id=171&option=com_virtuemart","DOI":"10.4149\/BLL_2021_078"},{"key":"1917_CR22","doi-asserted-by":"publisher","first-page":"680","DOI":"10.3109\/09537104.2014.979340","volume":"26","author":"S Balta","year":"2015","unstructured":"Balta S, Ozturk C. The platelet-lymphocyte ratio: a simple, inexpensive and rapid prognostic marker for cardiovascular events. Platelets. 2015;26:680\u20131. https:\/\/doi.org\/10.3109\/09537104.2014.979340.","journal-title":"Platelets"},{"key":"1917_CR23","doi-asserted-by":"publisher","first-page":"2595","DOI":"10.1016\/j.jstrokecerebrovasdis.2017.06.019","volume":"26","author":"H Ren","year":"2017","unstructured":"Ren H, Liu X, Wang L, Gao Y. Lymphocyte-to-Monocyte Ratio: A Novel Predictor of the Prognosis of Acute Ischemic Stroke. J Stroke Cerebrovasc Dis. 2017;26:2595\u2013602.\u00a0https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1052305717303026","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"1917_CR24","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1167\/iovs.14-15299","volume":"56","author":"I-H Yang","year":"2015","unstructured":"Yang I-H, Wong J-H, Chang C-M, Chen B-K, Tsai Y-T, Chen W-C et al. Involvement of Intracellular Calcium Mobilization in IL-8 Activation in Human Retinal Pigment Epithelial Cells. Invest Ophthalmol Vis Sci. 2015;56:761\u20139. http:\/\/iovs.arvojournals.org\/Article.aspx?doi=10.1167\/iovs.14-15299","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1917_CR25","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.0660-09.2009","author":"J Liu","year":"2009","unstructured":"Liu J, Tang TS, Tu H, Nelson O, Herndon E, Huynh DP, et al. Deranged calcium signaling and neurodegeneration in spinocerebellar ataxia type 2. J Neurosci. 2009. https:\/\/doi.org\/10.1523\/JNEUROSCI.0660-09.2009.","journal-title":"J Neurosci"},{"key":"1917_CR26","doi-asserted-by":"publisher","unstructured":"Dennis A-G, Almaguer-Mederos LE, Ra\u00fal R-A, Roberto R-L, Luis V-P, Dany C-A, et al. Redox imbalance associates with clinical worsening in spinocerebellar ataxia type 2. Oxid Med Cell Longev. 2021. https:\/\/doi.org\/10.1155\/2021\/9875639.","DOI":"10.1155\/2021\/9875639"},{"key":"1917_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.mito.2017.03.001","author":"N Cornelius","year":"2017","unstructured":"Cornelius N, Wardman JH, Hargreaves IP, Neergheen V, Bie AS, T\u00fcmer Z, et al. Evidence of oxidative stress and mitochondrial dysfunction in spinocerebellar ataxia type 2 (SCA2) patient fibroblasts: effect of coenzyme Q10 supplementation on these parameters. Mitochondrion. 2017. https:\/\/doi.org\/10.1016\/j.mito.2017.03.001.","journal-title":"Mitochondrion"},{"key":"1917_CR28","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1093\/rheumatology\/keu016","volume":"53","author":"MN Valc\u00e1rcel-Ares","year":"2014","unstructured":"Valc\u00e1rcel-Ares MN, Riveiro-Naveira RR, Vaamonde-Garc\u00eda C, Loureiro J, Hermida-Carballo L, Blanco FJ, et al. Mitochondrial dysfunction promotes and aggravates the inflammatory response in normal human synoviocytes. Rheumatology. 2014;53:1332\u201343.","journal-title":"Rheumatology"},{"key":"1917_CR29","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00089.2010","author":"SM Ivison","year":"2010","unstructured":"Ivison SM, Wang C, Himmel ME, Sheridan J, Delano J, Mayer ML, et al. Oxidative stress enhances IL-8 and inhibits CCL20 production from intestinal epithelial cells in response to bacterial flagellin. American Journal of Physiology-Gastrointestinal and Liver Physiology. 2010. https:\/\/doi.org\/10.1152\/ajpgi.00089.2010.","journal-title":"American Journal of Physiology-Gastrointestinal and Liver Physiology"},{"key":"1917_CR30","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.cyto.2016.06.023","volume":"87","author":"R Bonecchi","year":"2016","unstructured":"Bonecchi R, Garlanda C, Mantovani A, Riva F. Cytokine decoy and scavenger receptors as key regulators of immunity and inflammation. Cytokine. 2016;87:37\u201345. https:\/\/doi.org\/10.1016\/j.cyto.2016.06.023.","journal-title":"Cytokine"},{"key":"1917_CR31","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/S1471-4906(01)01941-X","volume":"22","author":"A Mantovani","year":"2001","unstructured":"Mantovani A, Locati M, Vecchi A, Sozzani S, Allavena P. Decoy receptors: a strategy to regulate inflammatory cytokines and chemokines. Trends Immunol. 2001;22:328\u201336.","journal-title":"Trends Immunol"},{"key":"1917_CR32","first-page":"33","volume":"19","author":"L Guo","year":"2018","unstructured":"Guo L, Louis IV-S, Bohjanen PR. Post-transcriptional regulation of cytokine expression and signaling. Curr Trends Immunol. 2018;19:33\u201340.\u00a0http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/30568341","journal-title":"Curr Trends Immunol"},{"key":"1917_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cytogfr.2023.12.002","volume":"77","author":"JM Messina","year":"2024","unstructured":"Messina JM, Luo M, Hossan MS, Gadelrab HA, Yang X, John A, et al. Unveiling cytokine charge disparity as a potential mechanism for immune regulation. Cytokine Growth Factor Rev. 2024;77:1\u201314.","journal-title":"Cytokine Growth Factor Rev"},{"key":"1917_CR34","doi-asserted-by":"crossref","unstructured":"Cytokines in the balance. Nat Immunol. 2019;20:1557\u20131557.\u00a0https:\/\/www.nature.com\/articles\/s41590-019-0557-0","DOI":"10.1038\/s41590-019-0557-0"},{"key":"1917_CR35","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.4049\/jimmunol.0902605","volume":"184","author":"EP Reeves","year":"2010","unstructured":"Reeves EP, Williamson M, Byrne B, Bergin DA, Smith SGJ, Greally P, et al. IL-8 dictates glycosaminoglycan binding and stability of IL-18 in cystic fibrosis. J Immunol. 2010;184:1642\u201352.","journal-title":"J Immunol"},{"key":"1917_CR36","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1080\/10408369991239196","volume":"36","author":"R Fernandez-Botran","year":"1999","unstructured":"Fernandez-Botran R. Soluble cytokine receptors: basic immunology and clinical applications. Crit Rev Clin Lab Sci. 1999;36:165\u2013224.","journal-title":"Crit Rev Clin Lab Sci"},{"key":"1917_CR37","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1152\/ajplung.2000.279.6.L1129","volume":"279","author":"DD Browning","year":"2000","unstructured":"Browning DD, Diehl WC, Hsu MH, Schraufstatter IU, Ye RD. Autocrine regulation of interleukin-8 production in human monocytes. Am J Physiol-Lung Cell Mol Physiol. 2000;279:1129\u201336.","journal-title":"Am J Physiol-Lung Cell Mol Physiol"},{"key":"1917_CR38","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.molimm.2025.02.003","volume":"179","author":"JN Fung","year":"2025","unstructured":"Fung JN, Lee JD, Adam R, O\u2019Sullivan JD, Woodruff TM. Peripheral and central elevation of IL-8 in patients with Huntington\u2019s disease. Mol Immunol. 2025;179:84\u201393. https:\/\/doi.org\/10.1016\/j.molimm.2025.02.003.","journal-title":"Mol Immunol"},{"key":"1917_CR39","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1084\/jem.20080178","volume":"205","author":"M Bj\u00f6rkqvist","year":"2008","unstructured":"Bj\u00f6rkqvist M, Wild EJ, Thiele J, Silvestroni A, Andre R, Lahiri N, et al. A novel pathogenic pathway of immune activation detectable before clinical onset in huntington\u2019s disease. J Exp Med. 2008;205:1869\u201377.","journal-title":"J Exp Med"},{"key":"1917_CR40","doi-asserted-by":"publisher","first-page":"578243","DOI":"10.1016\/j.jneuroim.2023.578243","volume":"385","author":"A Soltani Khaboushan","year":"2023","unstructured":"Soltani Khaboushan A, Moeinafshar A, Ersi MH, Teixeira AL, Majidi Zolbin M, Kajbafzadeh A-M. Circulating levels of inflammatory biomarkers in Huntington\u2019s disease: A systematic review and meta-analysis. J Neuroimmunol. 2023;385:578243.\u00a0https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572823002291","journal-title":"J Neuroimmunol"},{"key":"1917_CR41","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/s41598-017-00047-5","volume":"7","author":"Y Hu","year":"2017","unstructured":"Hu Y, Cao C, Qin XY, Yu Y, Yuan J, Zhao Y, et al. Increased peripheral blood inflammatory cytokine levels in amyotrophic lateral sclerosis: a meta-analysis study. Sci Rep. 2017;7:12\u20135.","journal-title":"Sci Rep"},{"key":"1917_CR42","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1212\/01.wnl.0000333251.36681.a5","volume":"72","author":"RM Mitchell","year":"2009","unstructured":"Mitchell RM, Freeman WM, Randazzo WT, Stephens HE, Beard JL, Simmons Z, et al. A CSF biomarker panel for identification of patients with amyotrophic lateral sclerosis. Neurology. 2009;72:14\u20139.","journal-title":"Neurology"},{"key":"1917_CR43","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.intimp.2018.01.036","volume":"56","author":"ME Meniailo","year":"2018","unstructured":"Meniailo ME, Malashchenko VV, Shmarov VA, Gazatova ND, Melashchenko OB, Goncharov AG, et al. Interleukin-8 favors pro-inflammatory activity of human monocytes\/macrophages. Int Immunopharmacol. 2018;56:217\u201321. https:\/\/doi.org\/10.1016\/j.intimp.2018.01.036.","journal-title":"Int Immunopharmacol."},{"key":"1917_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2022.155828","author":"K Matsushima","year":"2022","unstructured":"Matsushima K, Yang D, Oppenheim JJ. Interleukin-8: an evolving chemokine. Cytokine. 2022. https:\/\/doi.org\/10.1016\/j.cyto.2022.155828.","journal-title":"Cytokine"},{"key":"1917_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fcell.2023.1104393","volume":"11","author":"J Fu","year":"2023","unstructured":"Fu J, Chen S, Liu J, Yang J, Ou R, Zhang L, et al. Serum inflammatory cytokines levels and the correlation analyses in parkinson\u2019s disease. Front Cell Dev Biol. 2023;11:1\u20138.","journal-title":"Front Cell Dev Biol"}],"container-title":["The Cerebellum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12311-025-01917-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12311-025-01917-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12311-025-01917-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T20:03:30Z","timestamp":1768334610000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12311-025-01917-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,13]]},"references-count":45,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1917"],"URL":"https:\/\/doi.org\/10.1007\/s12311-025-01917-9","relation":{},"ISSN":["1473-4230"],"issn-type":[{"value":"1473-4230","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,13]]},"assertion":[{"value":"18 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the ethics committee of the Cuban Centre for Neurosciences (Havana, Cuba), and was conducted according to the Declaration of Helsinki. Written informed consent was obtained from each participant.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval Statements"}},{"value":"All authors received funding from the Cuban Ministry of Science, Technology and Environment, the Cuban Ministry of Public Health. YVM, RRL and LVP received funding from the Alexander von Humboldt Foundation. None has received any other funding for the last 12 months relevant or not for this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Financial Disclosure"}},{"value":"This dataset is not publicly available and can be asked from the Cuban authors directly upon reasonable request.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data Sharing Statement"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"165"}}